SINTX Technologies has engaged Southern Metrics Consulting, led by veteran MedTech executive Chris Lyons, to establish and manage a Strategic Opportunity Management Program. This program aims to systematically identify and evaluate growth opportunities such as partnerships, licensing, investments, and acquisitions to enhance shareholder value. The move reflects SINTX's transition from a development-focused company to a commercial-stage medical technology firm with expanding applications in orthopedics and other fields. Chris Lyons will continue serving on the SINTX board while guiding the company’s strategic growth efforts.
OS Therapies announced $10 million in debt financing supported by UK VAT refunds and R&D tax credits, providing financial stability into 2027. The company is preparing for key FDA and MHRA meetings in September 2026 to review survival data and finali...
Zentek Ltd. has filed a provisional patent for ZEN-EMI-01, a water-based electromagnetic interference (EMI) shielding coating made from purified graphite from its Albany deposit. Unlike traditional metal-based shields that reflect EM energy, this coa...
A new 2026 tax rule phases out a bonus deduction for taxpayers aged 65 and older based on modified adjusted gross income (MAGI). Retirees doing Roth IRA conversions to fill tax brackets may unintentionally lose this valuable deduction if their MAGI e...
Solana (SOL) is trading near $75, maintaining support above the crucial $60-$62 zone after a significant decline from its $253 peak. The recent Alpenglow upgrade, which drastically reduces transaction finality times, has been approved by over 98% of ...
Nebius (NBIS) has been upgraded to a Buy rating due to positive technical signals and strong momentum in the AI sector. The company benefits from over $40 billion in customer commitments, asset-light partnerships, and growing recurring revenue stream...
